Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical digoxin + furosemide proof-of-concept study in cutaneous warts
2014-003688-39Phase 2Completed
- Sponsor
- Biofrontera
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of digoxin and furosemide in verruca, common wart and plantar wart (2 arms), sponsored by Biofrontera. Primary endpoint: Reduction in wart area after six weeks of treatment. Started Nov 2014; status: completed.
02
Drugs
digoxinfurosemide
03
Conditions
verrucacommon wartplantar wart
Beyond the preview
Go deeper on 2014-003688-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003688-39.